Prevention of rheumatic fever. A comparative study of clindamycin palmitat and ampicillin in the treatment of group A beta hemolytic streptococcal pharyngitis.
D000284:Administration, Oral; D000667:Ampicillin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D007223:Infant; D007958:Leukocyte Count; D008034:Lincomycin / Q000627:therapeutic use*; D010612:Pharyngitis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D010614:Pharynx / Q000382:microbiology; D012213:Rheumatic Fever / Q000209:etiology / Q000517:prevention & control*; D012996:Solutions; D013290:Streptococcal Infections / Q000188:drug therapy*; D013291:Streptococcus / Q000302:isolation & purification
D012996:Solutions; D002981:Clindamycin; D000667:Ampicillin; D008034:Lincomycin